Meeting News

In explaining rise of obesity, diabetes, look toward unanswered questions

November 8, 2019
LAS VEGAS— The epidemics of obesity and type 2 diabetes continue to grow, and several challenging questions may hold the clues to targeting the…

HBV update: 5 reports on best practices toward elimination

November 8, 2019
Researchers are beginning to define the early steps toward a potential hepatitis B cure. In the meantime, hepatitis B care remains focused on finding…

Ocuphire advances Nyxol to address varied ocular indications

November 8, 2019
Ocuphire Pharma Inc. will prioritize the development of Nyxol eye drops for three indications following positive topline results from two phase 2…
Feature

Crisis pregnancy centers pose risk to adolescent health, experts say

November 8, 2019
The Society for Adolescent Health and Medicine, or SAHM, and the North American Society for Pediatric and Adolescent Gynecology, or NASPAG, published…
In the Journals

Albumin, liver stiffness after DAA therapy for HCV stratify liver cancer risk

November 8, 2019
Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients…
Meeting News

Entyvio exhibits favorable real-world safety profile in biologic-naive IBD patients

November 8, 2019
SAN ANTONIO — Entyvio was associated with significantly fewer serious adverse events and serious infections compared with anti-TNF therapy in…
Video

VIDEO: Eyevance co-founder highlights recent activities

November 8, 2019
ORLANDO, Fla. – Eyevance Pharmaceuticals has completed seven transactions over the last 2 years that have resulted in the company bringing 10…
FDA News

FDA accepts new drug application for acne cream

November 8, 2019
The FDA has accepted for review the new drug application for clascoterone cream 1% and has set Aug. 27, 2020, as the Prescription Drug User Fee Act…
Meeting NewsVideo

VIDEO: Why aren't hospitals using new antibiotics?

November 8, 2019
WASHINGTON — In this video from the World Anti-Microbial Resistance Congress, Debra A. Goff, PharmD, FIDSA, an infectious diseases specialist…
Meeting News

Top pulmonology news from October: ERS International Congress coverage, effects of e-cigarettes and more

November 8, 2019
Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in October. See below for links…
In the Journals

Experts optimize the total-body skin exam

November 8, 2019
Researchers developed a standardized total-body skin examination procedure using video recordings of dermatology faculty members and residents…
Meeting News

Consider hypoglycemia risks when helping adults with diabetes lose weight

November 8, 2019
LAS VEGAS — When treating patients with type 2 diabetes who are attempting to lose weight, physicians must incorporate strategies that limit…
Blog

BLOG Observations regarding the trochlea morphology in trochlea dysplasia

November 8, 2019
by John P. Fulkerson, MD Dysplasia of the femoral trochlea is complex and variable. Why it occurs is poorly understood. Some believe that trochlea…
Meeting News

ACAAI Scientific Meeting to highlight clinical updates

November 8, 2019
HOUSTON — Healio Primary Care will offer live coverage of the American College of Allergy, Asthma, and Immunology Annual Scientific Meeting…

Cedars-Sinai receives $10.5 million to study RP stem cell treatment

November 8, 2019
Cedars-Sinai researchers have received a $10.5 million grant from the California Institute for Regenerative Medicine to launch a clinical trial…
Editorial

Oncology Care Model: Progress along the learning curve

HemOnc Today, November 10, 2019
John Sweetenham, MD
Recognizing the importance of addressing value in cancer care, I have been an interested observer, until recently, of the progress of CMS’s…
Point/Counter

Will the use of PARP inhibitors in advanced ovarian cancer with wild-type BRCA lead to improved OS rates?

HemOnc Today, November 10, 2019
POINT Significant survival benefits can be hidden in the noise of any clinical trial. Part of this is due to the success we’ve had recently in…
Cover Story

PARP inhibitors take big step toward changing practice

HemOnc Today, November 10, 2019
With four FDA-approved agents and several potentially practicing-changing studies presented at medical conferences this year, the role of…
Meeting News

Study: ANG-3777 improves renal function in transplant recipients with delayed graft function

November 8, 2019
WASHINGTON — ANG-3777, a hepatocyte growth factor mimetic, may be an effective treatment for delayed graft function in patients undergoing…
Meeting News

Creatine equations comparable to measured GFR for HIV-positive patients

November 8, 2019
WASHINGTON — Ritonavir-boosted protease inhibitors do not significantly impact creatinine-based GFR estimates compared with measured GFR for…